Covid-19: US: Vaccines get emergency use approval for young children

Covid-19: US: Vaccines get emergency use approval for young children

In the United States, children between the ages of six months and five years can now get a vaccine against the coronavirus.

The corona vaccines from the manufacturers Biontech/Pfizer and Moderna are now also approved in the USA for children between the ages of six months and five years.

The US Food and Drug Administration (FDA) has given them emergency use approvals for this age group, the manufacturers said. Previously, after hours of discussion, an advisory board to the FDA unanimously voted in favor of it. This could soon start vaccinations against the corona virus in this age group in the USA. A few days ago, the US government said that this would be expected from around June 21st.

Previously, Biontech/Pfizer’s vaccine was approved in the United States for children ages five to 11, and Moderna’s vaccine for people ages 18 and older. The Moderna vaccine has now also received emergency approval for children and adolescents between the ages of 6 and 17.

There is currently no corona vaccine approved for very young children in the EU. The European Medicines Agency EMA in Amsterdam is currently examining whether the vaccine from the manufacturer Moderna (Spikevax) can also be approved for children under the age of six. Such a test has not yet started for the vaccine from the manufacturers Biontech and Pfizer. According to the EMA, the manufacturers have not yet submitted a corresponding application for an extension of the approval.

Source: Stern

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest Posts